Will Beta

Main Menu

  • Volatility
  • Systematic Risk
  • Returns Of Assets
  • Beta Data
  • Finance Debt

Will Beta

Header Banner

Will Beta

  • Volatility
  • Systematic Risk
  • Returns Of Assets
  • Beta Data
  • Finance Debt
Beta Data
Home›Beta Data›Pfizer-BioNTech to request authorization for a 3rd Covid shot: press release

Pfizer-BioNTech to request authorization for a 3rd Covid shot: press release

By Rogers Jennifer
July 8, 2021
0
0



Published on: 07/09/2021 – 01:04Amended: 07/09/2021 – 01:02

Washington (AFP)

Pfizer and BioNTech announced Thursday that they will seek regulatory approval for a third dose of their Covid-19 vaccine.

It comes after initial data from an ongoing trial showed that a third hit pushed antibody levels five to 10 times higher against the original coronavirus strain and the beta variant, first found. times in South Africa, compared to the first two doses alone, according to a statement.

“The companies plan to publish more definitive data soon as well as in a peer-reviewed journal and plan to submit the data to the Food and Drug Administration (FDA), EMA (European Medicines Agency) and others. regulatory authorities in the coming weeks, “the statement said.

In addition, the companies expect a third dose to be equally effective against the highly transmissible strain Delta, which is rapidly becoming dominant globally.

To be on the safe side, the companies are also developing a vaccine specific to Delta, the first batch of which was manufactured at BioNTech’s plant in Mainz, Germany.

The companies expect clinical studies to begin in August, subject to regulatory approvals.

The companies added that, based on the drops in efficacy seen in Israel after six months, they believe a third dose may be needed within six to 12 months of the full vaccination.

“While protection against serious illness has remained high for the full 6 months, a decline in efficacy against symptomatic illnesses over time and the continued emergence of variants are expected,” the statement said.

© 2021 AFP



Related posts:

  1. Morgan Stanley lowers its price target (NASDAQ: INCY) to $ 85.00
  2. Red Light Holland iMicro Digital Care app and teleconsultation launched
  3. CME says over 100,000 micro-bitcoin futures traded in the first six days
  4. Euro-dollar draws confidence from ZEW data and USD Ebbing

Recent Posts

  • “Mathematics does not account for human emotions” – News Bitcoin News
  • Economic daily: the role of real estate in stabilizing the economy is emerging
  • ‘Race against time’ to sell Slough properties and land
  • Organic Asparagus Market Size and Forecast to 2028 | Altar Produce, DanPer, Beta SA, AEI, Agrizar – Designer Women
  • SoFi Technologies (NASDAQ:SOFI) vs Northern Lights Acquisition (NASDAQ:NLIT) Direct Survey

Archives

  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • January 2022
  • December 2021
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021

Categories

  • Beta Data
  • Finance Debt
  • Returns Of Assets
  • Systematic Risk
  • Volatility
  • Terms and Conditions
  • Privacy Policy